Journal article
Predictors of Health Care Utilization for Individuals With Manifest Huntington Disease
Neurology. Clinical practice, Vol.15(3), e200471
06/2025
DOI: 10.1212/CPJ.0000000000200471
PMCID: PMC12021023
PMID: 40290707
Abstract
Background and Objectives
There is a need to understand how different factors influence health care utilization for patients with Huntington disease (HD) to maximize benefits of primary and specialty care while minimizing need for costly emergency visits or hospitalizations. The primary objective of this study was to characterize how settings where patients with HD in Northern America receive care change throughout the disease course and determine whether the likelihood of different types of service utilization is influenced by clinical, sociodemographic, and caregiver characteristics.
Methods
Data from the Enroll-HD study and joinpoint regression were used to assess trends in neurology visits, general practitioner visits, emergency department visits, and inpatient stays over the disease course and as a function of total functional capacity. Generalized estimating equation models were then used to identify factors associated with use of these different services in the 6 months before their study visit.
Results
Visits from 1,631 participants in the Northern America region from the Enroll-HD study were included in this study. Trends in neurology, emergency, and inpatient visits remained constant over most of the disease duration. For the general practitioner visits, there was an increasing trend in use throughout the course of disease. Clinical factors, such as psychiatric symptoms, functional ability, and comorbidities, were associated with use of multiple types of health care services. Sociodemographic and caregiver factors, such as race or ethnicity, urban or rural residence, and caregiver employment status, were also associated with use of multiple health care services.
Discussion
Clinical, sociodemographic, and caregiver-related factors were all associated with outpatient, emergent, and inpatient care. This work identifies multiple avenues for future research on how to improve access to and quality of care for patients with HD, specifically relating to reducing the need for emergency visits and inpatient stays and promoting collaboration among primary and specialty clinicians.
Details
- Title: Subtitle
- Predictors of Health Care Utilization for Individuals With Manifest Huntington Disease
- Creators
- Amy C. OgilvieRyan M. CarnahanAdys MendizabalStephanie Gilbertson-WhiteAaron T. SeamanElizabeth A. ChrischillesJordan L. Schultz
- Resource Type
- Journal article
- Publication Details
- Neurology. Clinical practice, Vol.15(3), e200471
- DOI
- 10.1212/CPJ.0000000000200471
- PMID
- 40290707
- PMCID
- PMC12021023
- NLM abbreviation
- Neurol Clin Pract
- ISSN
- 2163-0402
- eISSN
- 2163-0933
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS; PHILADELPHIA
- Grant note
- CHDI Foundation, Inc.CHDI Foundation: AcknowledgementsListPDS6_v1.0_20230119
Data used in this work were generously provided by the participants in the Enroll-HD study and made available by CHDI Foundation, Inc. Enroll-HD is a clinical research platform and longitudinal observational study for Huntington disease families intended to accelerate progress toward therapeutics; it is sponsored by CHDI Foundation, a nonprofit biomedical research organization exclusively dedicated to collaboratively developing therapeutics for HD. Enroll-HD would not be possible without the vital contribution of the research participants and their families (enroll-hd.org/enrollhd_documents/ENROLL-HD_AcknowledgementsListPDS6_v1.0_20230119.pdf).
- Language
- English
- Date published
- 06/2025
- Academic Unit
- Neurology; Pharmacy; Psychiatry; Epidemiology; Iowa Neuroscience Institute; Nursing; Pharmacy Practice and Science; Center for Social Science Innovation; Injury Prevention Research Center; General Internal Medicine; Community and Behavioral Health; Internal Medicine
- Record Identifier
- 9984810949202771
Metrics
6 Record Views